Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 42

1.

Gender differences in the relationship between symptoms of depression and high-sensitivity CRP.

Vetter ML, Wadden TA, Vinnard C, Moore RH, Khan Z, Volger S, Sarwer DB, Faulconbridge LF; POWER-UP Research Group.

Int J Obes (Lond). 2013 Aug;37 Suppl 1:S38-43. doi: 10.1038/ijo.2013.95.

PMID:
23921781
2.

Managing obesity in primary care practice: an overview with perspective from the POWER-UP study.

Wadden TA, Volger S, Tsai AG, Sarwer DB, Berkowitz RI, Diewald LK, Carvajal R, Moran CH, Vetter M; POWER-UP Research Group.

Int J Obes (Lond). 2013 Aug;37 Suppl 1:S3-11. doi: 10.1038/ijo.2013.90. Review.

PMID:
23921779
3.

The impact of a primary care-based weight loss intervention on the quality of life.

Sarwer DB, Moore RH, Diewald LK, Chittams J, Berkowitz RI, Vetter M, Volger S, Wadden TA; POWER-UP Research Group.

Int J Obes (Lond). 2013 Aug;37 Suppl 1:S25-30. doi: 10.1038/ijo.2013.93.

PMID:
23921778
4.

Effect of lifestyle intervention on cardiometabolic risk factors: results of the POWER-UP trial.

Vetter ML, Wadden TA, Chittams J, Diewald LK, Panigrahi E, Volger S, Sarwer DB, Moore RH; POWER-UP Research Group.

Int J Obes (Lond). 2013 Aug;37 Suppl 1:S19-24. doi: 10.1038/ijo.2013.92.

PMID:
23921777
5.

Changes in eating, physical activity and related behaviors in a primary care-based weight loss intervention.

Volger S, Wadden TA, Sarwer DB, Moore RH, Chittams J, Diewald LK, Panigrahi E, Berkowitz RI, Schmitz K, Vetter ML; POWER-UP Research Group.

Int J Obes (Lond). 2013 Aug;37 Suppl 1:S12-8. doi: 10.1038/ijo.2013.91.

PMID:
23921776
6.

Angiotensin-converting enzyme inhibitors: new orally active 1,4-thiazepine-2,5-diones, 1,4-thiazine-2,5-diones, and 1,4-benzothiazepine-2,5-diones possessing antihypertensive activity.

Skiles JW, Suh JT, Williams BE, Menard PR, Barton JN, Loev B, Jones H, Neiss ES, Schwab A, Mann WS, et al.

J Med Chem. 1986 May;29(5):784-96.

PMID:
3009814
7.

Angiotensin converting enzyme inhibitors. (Mercaptoaroyl)amino acids.

Menard PR, Suh JT, Jones H, Loev B, Neiss ES, Wilde J, Schwab A, Mann WS.

J Med Chem. 1985 Mar;28(3):328-32.

PMID:
2983075
8.

1,2,4-Triazolo[4,3-a]quinoxaline-1,4-diones as antiallergic agents.

Loev B, Musser JH, Brown RE, Jones H, Kahen R, Huang FC, Khandwala A, Sonnino-Goldman P, Leibowitz MJ.

J Med Chem. 1985 Mar;28(3):363-6.

PMID:
2579236
9.

Angiotensin-converting enzyme inhibitors. New orally active antihypertensive (mercaptoalkanoyl)- and [(acylthio)alkanoyl]glycine derivatives.

Suh JT, Skiles JW, Williams BE, Youssefyeh RD, Jones H, Loev B, Neiss ES, Schwab A, Mann WS, Khandwala A, et al.

J Med Chem. 1985 Jan;28(1):57-66.

PMID:
2981324
10.

[1,4]Benzoxazine-2,3-diones as antiallergic agents.

Loev B, Jones H, Brown RE, Huang FC, Khandwala A, Leibowitz MJ, Sonnino-Goldman P.

J Med Chem. 1985 Jan;28(1):24-7.

PMID:
2578192
11.

Pyrido[3',2':4,5]thieno[3,2-d]-N-triazines: a new series of orally active antiallergic agents.

Youssefyeh RD, Brown RE, Wilson J, Shah U, Jones H, Loev B, Khandwala A, Leibowitz MJ, Sonnino-Goldman P.

J Med Chem. 1984 Dec;27(12):1639-43.

PMID:
6150114
12.

Angiotensin-converting enzyme inhibitory and antihypertensive activities of pivalopril (RHC 3659-(S)).

Wolf PS, Mann WS, Suh JT, Loev B, Smith RD.

Fed Proc. 1984 Apr;43(5):1322-5.

PMID:
6323222
13.

Synthesis of 2-(2,3-dihydro-2-oxo-1,3,4-oxadiazol-5-yl) benzo heterocycles. A novel series of orally active antiallergic agents.

Musser JH, Brown RE, Loev B, Bailey K, Jones H, Kahen R, Huang FC, Khandwala A, Leibowitz M, Sonnino-Goldman P, et al.

J Med Chem. 1984 Feb;27(2):121-5.

PMID:
6198518
14.

Antiallergic activity profiles in vitro of RHC 3164 and related compounds. I. A lack of correlation between inhibition of cyclic nucleotide phosphodiesterases and antigen-induced release of histamine from rat mast cells.

Khandwala A, Van Inwegen R, Coutts S, Dally-Meade V, Jariwala N, Huang F, Musser J, Brown R, Loev B, Weinryb I.

Int Arch Allergy Appl Immunol. 1984;73(1):56-64.

PMID:
6198287
15.

RHC 3288 [1-methyl-2(1,3,4-oxadiazol-2(3H)-one-5-yl) benzimidazole] and related compounds. Novel inhibitors of histamine release from rat mast cells and human basophils.

Khandwala A, Coutts S, Dally-Meade V, Jariwala N, Musser J, Brown R, Jones H, Loev B, Weinryb I.

Biochem Pharmacol. 1983 Nov 15;32(22):3325-33.

PMID:
6197075
16.

Gastric antisecretory 9H-xanthen-9-amines.

Bender PE, Perchonock CD, Groves WG, Smith RC Jr, Stringer OD, Sneed R, Schlosser JH, Hostelley LS, Hwang BY, Eby RZ, Konicki G, Lavanchy PG, Wilson JW 3rd, Loev B.

J Med Chem. 1983 Sep;26(9):1218-23.

PMID:
6887196
17.

1,3-Diaryltriazenes: a new class of anorectic agents.

Hill DT, Stanley KG, Williams JE, Loev B, Fowler PJ, McCafferty JP, Macko E, Berkoff CE, Ladd CB.

J Med Chem. 1983 Jun;26(6):865-9.

PMID:
6854589
18.

Synthesis of some aromatic prostaglandin analogs.

Perchonock CD, Loev B.

Prostaglandins. 1978 Apr;15(4):623-7.

PMID:
674693
19.
20.

Supplemental Content

Loading ...
Support Center